ISPOR 23rd International Meeting Article Collections

Value and Pricing

Cost-Effectiveness Analysis

Personalized Medicine

  • Evaluating Frameworks That Provide Value Measures for Health Care Interventions

    Jeanne S. Mandelblatt, Scott D. Ramsey, Tracy A. Lieu, Charles E. Phelps
    Vol. 20, Issue 2, p185–192
    Open Archive
  • Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice

    Marc B. Rosenman, Brian Decker, Kenneth D. Levy, Ann M. Holmes, Victoria M. Pratt, Michael T. Eadon
    Vol. 20, Issue 1, p54–59
    Open Archive
  • “What Goes Around Comes Around”: Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine

    Kathryn A. Phillips, Michael P. Douglas, Julia R. Trosman, Deborah A. Marshall
    Vol. 20, Issue 1, p47–53
    Open Archive
  • Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?

    Martine Hoogendoorn, Talitha L. Feenstra, Yumi Asukai, Andrew H. Briggs, Sixten Borg, Roberto W. Dal Negro, Ryan N. Hansen, Sven-Arne Jansson, Reiner Leidl, Nancy Risebrough, Yevgeniy Samyshkin, Margarethe E. Wacker, Maureen P.M.H. Rutten-van Mölken
    Vol. 19, Issue 6, p800–810
    Open Archive
  • Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies

    Julia R. Trosman, Christine B. Weldon, Michael P. Douglas, Patricia A. Deverka, John B. Watkins, Kathryn A. Phillips
    Vol. 20, Issue 1, p40–46
    Open Archive
  • Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine

    Deborah A. Marshall, Juan Marcos Gonzalez, Karen V. MacDonald, F. Reed Johnson
    Vol. 20, Issue 1, p32–39
    Open Archive
Advertisement